Amalgamated Bank Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Amalgamated Bank

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$144.95 - $152.29 $35,512 - $37,311	245 Added 2.67%	9,437 $1.43 Million
Q2 2022 Aug 15, 2022	BUY	$83.14 - $145.99 $71,749 - $125,989	863 Added 10.36%	9,192 $1.34 Million
Q1 2022 Jun 30, 2022	SELL	$110.08 - $142.92 $68,689 - $89,182	-624 Reduced 6.97%	8,329 $988,000
Q4 2021 Feb 15, 2022	SELL	$99.73 - $148.48 $8,776 - $13,066	-88 Reduced 0.97%	8,953 $1.23 Million
Q3 2021 Oct 29, 2021	SELL	$98.85 - $138.91 $30,248 - $42,506	-306 Reduced 3.27%	9,041 $1.26 Million
Q2 2021 Aug 16, 2021	BUY	$65.78 - $105.02 $164,252 - $262,234	2,497 Added 36.45%	9,347 $907,000
Q1 2021 May 13, 2021	SELL	$64.07 - $91.75 $42,798 - $61,289	-668 Reduced 8.89%	6,850 $468,000
Q4 2020 Feb 12, 2021	BUY	$65.07 - $98.24 $2,602 - $3,929	40 Added 0.53%	7,518 $644,000
Q3 2020 Oct 30, 2020	SELL	$59.04 - $77.95 $4,191 - $5,534	-71 Reduced 0.94%	7,478 $486,000
Q2 2020 Aug 10, 2020	BUY	$29.01 - $74.23 $5,279 - $13,509	182 Added 2.47%	7,549 $552,000
Q1 2020 May 13, 2020	BUY	$27.51 - $57.29 $5,446 - $11,343	198 Added 2.76%	7,367 $251,000
Q4 2019 Feb 13, 2020	BUY	$40.86 - $57.65 $25,128 - $35,454	615 Added 9.38%	7,169 $390,000
Q3 2019 Nov 13, 2019	BUY	$37.38 - $49.47 $21,979 - $29,088	588 Added 9.86%	6,554 $273,000
Q2 2019 Aug 14, 2019	BUY	$39.79 - $67.01 $49,817 - $83,896	1,252 Added 26.56%	5,966 $261,000
Q1 2019 May 15, 2019	BUY	$34.52 - $53.29 $162,727 - $251,209	4,714 New	4,714 $243,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

Stay updated on Amalgamated Bank with notifications on news.